• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性嗜铬细胞瘤:1966年至1990年间观察的14例病例系列

Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990.

作者信息

Mornex R, Badet C, Peyrin L

机构信息

Service d'Endocrinologie, Pavillon X, Hôpital Edouard Herriot, Lyon, France.

出版信息

J Endocrinol Invest. 1992 Oct;15(9):643-9. doi: 10.1007/BF03345808.

DOI:10.1007/BF03345808
PMID:1479147
Abstract

We report 14 patients (9 males, 5 females) aged 15-59 years, treated for malignant pheochromocytoma. These patients were observed during the 1966-1990 period along with 68 other patients presenting benign pheochromocytomas. From the initial general presentation of the 14 patients, two groups could be individualized. In seven patients, the initial presentation seemed benign. After the excision, the recovery was complete, but patients recurred on average 7.8 yr later (range 1-22 yr). Tumors were intraadrenal in six cases (5 single, 1 bilateral) and extraadrenal in one case. In the seven remaining patients, malignancy was evident from the first examination. The tumors were intraadrenal in 2 cases, extraadrenal in 5 cases. Frequency of extraadrenal locations (6/14) was in this series significantly higher than in benign forms (9/68). Diagnosis of malignancy was based on metastases in 12 cases (lymph nodes in 5, bones in 5, liver in 4, lung in 2, brain in 1) and on peritumoral extension in 2 cases. No biological specificity was detected in urinary excretion of catecholamines or its metabolites. In 6 patients so far studied, an uptake of 131I MIBG was found in the tumor and/or metastases. Four patients received therapeutic doses of 131I MIBG and in three of them, this treatment led to a good result within a follow-up range of 12 to 66 months.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们报告了14例年龄在15至59岁之间接受恶性嗜铬细胞瘤治疗的患者(9例男性,5例女性)。在1966年至1990年期间对这些患者进行了观察,同时还有68例患有良性嗜铬细胞瘤的患者。从这14例患者最初的总体表现来看,可以分为两组。7例患者最初的表现看似良性。切除术后恢复完全,但患者平均在7.8年后复发(范围为1至22年)。肿瘤位于肾上腺内6例(5例单发,1例双侧),肾上腺外1例。其余7例患者从首次检查时恶性就很明显。肿瘤位于肾上腺内2例,肾上腺外5例。在本系列中,肾上腺外部位的发生率(6/14)显著高于良性病例(9/68)。恶性诊断基于12例转移(5例为淋巴结转移,5例为骨转移,4例为肝转移,2例为肺转移,1例为脑转移)和2例肿瘤周围浸润。在儿茶酚胺及其代谢产物的尿排泄中未检测到生物学特异性。在目前研究的6例患者中,在肿瘤和/或转移灶中发现了131I MIBG摄取。4例患者接受了治疗剂量的131I MIBG,其中3例在12至66个月的随访范围内治疗效果良好。(摘要截短至250字)

相似文献

1
Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990.恶性嗜铬细胞瘤:1966年至1990年间观察的14例病例系列
J Endocrinol Invest. 1992 Oct;15(9):643-9. doi: 10.1007/BF03345808.
2
Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.恶性嗜铬细胞瘤:20例伴有远处转移患者的临床、生物学、组织学及治疗数据
J Endocrinol Invest. 1992 Oct;15(9):631-42. doi: 10.1007/BF03345807.
3
High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991.某外科病房恶性嗜铬细胞瘤的高发病率。1971年至1991年期间,100例接受手术的患者中有26例患有此病。
J Endocrinol Invest. 1992 Oct;15(9):651-63. doi: 10.1007/BF03345810.
4
Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.用[131I]间碘苄胍治疗嗜铬细胞瘤。
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):292-4.
5
Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.用[131I]间碘苄胍治疗恶性嗜铬细胞瘤:一项法国多中心研究。
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):284-7.
6
Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.对三名恶性嗜铬细胞瘤患者进行[131I]间碘苄胍治疗的结果。
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):305-7.
7
[131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.[131I]间碘苄胍治疗恶性嗜铬细胞瘤:罗马研究组的经验
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):295-9.
8
[131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.20例恶性嗜铬细胞瘤患者的[131I]间碘苄胍治疗
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):288-91.
9
[131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):308-12.
10
Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.10例恶性嗜铬细胞瘤的临床和病理数据:单机构长期随访
Int J Urol. 2007 Mar;14(3):181-5. doi: 10.1111/j.1442-2042.2007.01687.x.

引用本文的文献

1
Pheochromocytoma metastasis to the central nervous system: a case report and systematic review.嗜铬细胞瘤转移至中枢神经系统:一例报告及系统综述
Front Endocrinol (Lausanne). 2025 Aug 25;16:1633411. doi: 10.3389/fendo.2025.1633411. eCollection 2025.
2
Malignant pheochromocytoma with cerebral and skull metastasis: A case report and literature review.恶性嗜铬细胞瘤伴脑和颅骨转移:一例报告及文献复习
World J Clin Cases. 2021 Apr 26;9(12):2791-2800. doi: 10.12998/wjcc.v9.i12.2791.
3
Pheochromocytoma with Brain Metastasis: A Extremely Rare Case in Worldwide.

本文引用的文献

1
SECRETION OF CATECHOLAMINES IN MALIGNANT PHAEOCHROMOCYTOMA.恶性嗜铬细胞瘤中儿茶酚胺的分泌
Br Med J. 1964 May 30;1(5395):1422-4. doi: 10.1136/bmj.1.5395.1422.
2
Multiple sequential pulmonary resections for metastatic pheochromocytoma with long-term survival.多次序贯性肺切除术治疗转移性嗜铬细胞瘤并长期生存
Am J Surg. 1980 Nov;140(5):696-7. doi: 10.1016/0002-9610(80)90061-6.
3
Pheochromocytoma: current status and changing trends.嗜铬细胞瘤:现状与变化趋势
伴有脑转移的嗜铬细胞瘤:全球极为罕见的病例
Brain Tumor Res Treat. 2018 Oct;6(2):101-104. doi: 10.14791/btrt.2018.6.e18.
4
What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.恶性嗜铬细胞瘤的死亡因素是什么?——一例存活18年的病例报告及文献综述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):264-269. doi: 10.20945/2359-3997000000033.
5
Splenectomy for splenic metastases from malignant adrenal pheochromocytoma: a case report.脾切除术治疗恶性肾上腺嗜铬细胞瘤脾转移:病例报告。
Cancer Biol Med. 2013 Jun;10(2):114-6. doi: 10.7497/j.issn.2095-3941.2013.02.009.
6
Pheochromocytomas and paragangliomas: assessment of malignant potential.嗜铬细胞瘤和副神经节瘤:恶性潜能评估。
Endocrine. 2011 Dec;40(3):354-65. doi: 10.1007/s12020-011-9545-3. Epub 2011 Oct 25.
7
Predictive characteristics of malignant pheochromocytoma.恶性嗜铬细胞瘤的预测特征。
Korean J Urol. 2011 Apr;52(4):241-6. doi: 10.4111/kju.2011.52.4.241. Epub 2011 Apr 22.
8
Pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤。
Prog Brain Res. 2010;182:343-73. doi: 10.1016/S0079-6123(10)82015-1.
9
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.肾上腺外腹膜后副神经节瘤切除 9 年后发生肝转移,切除肝转移后获得成功。
Int J Clin Oncol. 2009 Oct;14(5):473-7. doi: 10.1007/s10147-008-0872-1. Epub 2009 Oct 25.
10
Laparoscopic surgery for malignant adrenal tumors.恶性肾上腺肿瘤的腹腔镜手术
JSLS. 2009 Apr-Jun;13(2):196-202.
Surgery. 1982 Apr;91(4):367-73.
4
Clinico-pathological and ultrastructural characteristics of pheochromocytoma. An analysis of 55 cases.
Pathol Res Pract. 1984 Mar;178(4):355-62. doi: 10.1016/s0344-0338(84)80027-8.
5
Radiopharmaceutical treatment of malignant pheochromocytoma.恶性嗜铬细胞瘤的放射性药物治疗。
J Nucl Med. 1984 Feb;25(2):197-206.
6
Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization.恶性嗜铬细胞瘤:临床、生化及闪烁显像特征
Clin Endocrinol (Oxf). 1984 Feb;20(2):189-203. doi: 10.1111/j.1365-2265.1984.tb00074.x.
7
[Strategy for the biochemical study of pheochromocytoma].[嗜铬细胞瘤的生化研究策略]
Ann Med Interne (Paris). 1983;134(3):235-7.
8
Oncologic aspects of pheochromocytoma: the importance of follow-up.嗜铬细胞瘤的肿瘤学问题:随访的重要性。
Surgery. 1984 Dec;96(6):1061-6.
9
New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine.嗜铬细胞瘤定位的新方法:用碘-131-间碘苄胍进行成像
Br Med J (Clin Res Ed). 1984 May 26;288(6430):1587-91. doi: 10.1136/bmj.288.6430.1587.
10
Chemotherapy trials in malignant pheochromocytoma: report of two patients and review of the literature.恶性嗜铬细胞瘤的化疗试验:两例患者报告及文献综述
J Surg Oncol. 1984 Oct;27(2):89-92. doi: 10.1002/jso.2930270207.